期刊文献+

血清HE4在鉴别盆腔包块性质中的意义 被引量:1

The significance of serum Human Epididymis Protein 4 (HE4) in the identification of pelvic masses
原文传递
导出
摘要 目的:初步探讨人附睾蛋白4(HE4)在鉴别盆腔包块性质中的意义。方法:对2012年10月~12月拟"盆腔包块"在中山市博爱医院病房住院的50例患者及妇科门诊拟"健康体检"就诊的14例健康女性的静脉血标本作研究,分别检测HE4及癌胚抗原125(CA125)。并根据术后病理结果将盆腔包块患者分为三组,对HE4及CA125进行回顾性分析,分组如下:A组:对照组,即健康体检者;B组:卵巢良性肿瘤组,即术后病理证实为卵巢浆液性囊腺瘤,黄体囊肿,卵巢成熟性畸胎瘤等;C组:卵巢巧克力囊肿组,即术后病理证实为卵巢巧克力囊肿患者;D组:卵巢癌组,术后病理证实为卵巢癌患者。结果:A、B、C、D各组的血清HE4的值分别为(44.99±6.98)pmol/L、(48.54±11.35)pmol/L、(51.91±10.06)pmol/L、(119.17±94.94)pmol/L,经过统计学分析,D组的值与A、B、C组差异均有统计学意义(P<0.05)。A、B、C、D各组的血清CA125的值分别为(22.94±14.67)U/L、(19.23±11.06)U/L、(169.59±229.45)U/L、(80.42±72.22)U/L,经过统计学分析,C组的值与A、B组差异有统计学意义(P<0.05)。但与D组差异无统计学意义(P>0.05)。结论:HE4在盆腔包块的鉴别上有重要意义,值得进一步深入研究。 Objective: To preliminarily explore the significance of Human Epididymis Protein 4 (HE4) in the identification of pelvic masses. Methods: Serum HE4 and CA125 were detected by the proposed " pelvic mass" in 50 patients hospitalized in Zhongshan Boai Hospital ward from October 2012 to December 2012 and gynecological outpatient intends to " healthy" for treatment of 14 cases of healthy women, respectively. According to the result of pathological pelvic mass patients were divided into three groups, and given a retrospective analysis of HE4 and CA125, respectively. Grouped as follows : A group : control group of healthy persons ; B group : benign ovarian tumor group; C group: ovarian chocolate cyst group; D group- ovarian cancer group. Results: Serum HEA values in group A, B, C, and D were (44. 99 ±6. 98), (48.54 ±11.35), (51.91 ±10. 06), (119. 17 ±94. 94) pmol / L, respectively. There was statisti- cally significant between the group D and the group A, B, C , respectively. (P 〈 0. 05) . Serum CA125 values in A, B, C, and D group were (22. 94± 14. 67 ), ( 19. 23± 11.06 ), ( 169. 59± 229. 45), (80.42 ±72. 22) U/L, respectively. There was statistically significant between the group C and the group A, B, respectively. (P 〈 0. 05 ), bat not with group D ( P 〉 0. 05 ) . Conclusion : The serum HE4 level detection may be played an important role of the identification of pelvic masses, and it is worthy of iurther study.
出处 《中国妇幼保健》 CAS 北大核心 2013年第30期5068-5070,共3页 Maternal and Child Health Care of China
基金 广东省中山市科技技术项目〔20113A127〕
关键词 人附睾蛋白 癌胚抗原125 盆腔包块 Human epididymis protein Carcinoembryonic antigen 125 Pelvic masses
  • 相关文献

参考文献6

二级参考文献45

共引文献24

同被引文献22

  • 1Urban N,Thorpe JD,Bergan LA,et al. Potential role of HE4 in multimodal screening for epithelial ovarian cancer [J]. J Natl Cancer Inst ,2011,103 (21) : 1630-1634.
  • 2Lenhard M,Stieber P, Hertlein L,et al. The diagnostic accu- racy of two human epididymisprotein 4 (HE4)testing sys- tems in combination with CA125 in the differential diag- nosis of ovarian masses [J]. Clin Chem Lab Med,2011,49 (12) : 2081-2088.
  • 3Lawicki S,Bedkowska GE,Gacuta-Szumarska E,et aL The plasma concentration of VEGF,HE4 and CA125 as a new biomarkers panel in different stages and sub-types of ep- ithelialovarian tumors [J]. J Ovarian Res,2013,6(1):45.
  • 4Macuks R,Baidekalna I,Donina S. An ovarian cancer ma- lignancy risk index composed of HE4,CA125,uhrasono- graphic score, and menopausal status:use in differentiation of ovarian cancers and benign lesions [J]. Tumour Biol, 2012,33(5) : 1811-1817.
  • 5Montagnana M,Danese E,Ruzzenente O,et al. The ROMA (risk of ovarian malignancy algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass:is it really useful? [J]. Clin Chem Lab Med, 2011,49(3) :521-525.
  • 6Anastasi E,Granato T,Fatzarano R,et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian- cancer [J]. J Ovarian Res ,2013,6(1 ) :44.
  • 7Hamed EO,Ahmed H,Sedeek OB,et al. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response [J]. Diagn Pathol, 2013,8 : 11.
  • 8Kim YM, Whang DH, Park J, et al. Evaluation of the ac- curacy of serum human epididymisprotein 4 in combina- tion with CA125 for detecting ovariancancer:a prospec- tive case-control study in a Korean population [J]. Clin Chem Lab Med,2011,49(3) :527-534.
  • 9林仲秋.FIGO/IGCS妇科恶性肿瘤分期及临床实践指南(六):卵巢癌[J].国际妇产科学杂志,2008,35(6):459-461. 被引量:48
  • 10刘国瑞,王艾丽,刘琦,经卉,李梅,严孝岭,虞伟,李晓军.联合检测血清CA125和HE4用于卵巢癌诊断及鉴别诊断[J].临床检验杂志,2010,28(2):119-121. 被引量:39

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部